Ibugesic (Ibuprofen)

Ibuprofen works by reversibly inhibiting the cyclooxygenase‑1 and cyclo‑oxygenase‑2 enzymes, which blocks the conversion of arachidonic acid into prostaglandins. Reduced prostaglandin levels diminish peripheral sensitisation of pain receptors, lower the hypothalamic set‑point for body temperature, and limit inflammatory fluid exudation.

The appropriate dose of Ibugesic is determined by a qualified healthcare professional based on the patient’s age, weight, clinical condition and any relevant comorbidities. Prescribers follow local guidelines and label instructions to select the strength and frequency that provide effective symptom control while minimising risk.

Safety data for ibuprofen in pregnancy are limited; it is generally avoided in the third trimester because of potential fetal cardiovascular effects. Breastfeeding mothers should consult a healthcare provider, as ibuprofen does pass into milk in small amounts. Professional guidance is essential before use.

To place an order, submit an enquiry on the Ibugesic product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Ibugesic (ibuprofen) shares the core anti‑inflammatory, analgesic and antipyretic properties of the NSAID class, but its relatively short half‑life and balanced COX‑1/COX‑2 inhibition profile may offer a favorable safety margin compared with agents that are more COX‑2 selective or have longer duration, such as naproxen or diclofenac. Choice depends on individual risk factors and therapeutic goals.

Ibugesic should be stored at ambient temperature, preferably below 25 °C, in its original packaging to protect it from moisture, heat and direct sunlight. Keep the product out of reach of children and do not use it after the expiry date printed on the label.

Ibugesic is taken orally, usually with a full glass of water. It may be taken with or without food; however, consuming it with meals can lessen gastrointestinal discomfort. Patients should follow the dosing schedule prescribed by their healthcare professional and avoid crushing or chewing extended‑release forms if present.

The most serious adverse events linked to ibuprofen include gastrointestinal bleeding or ulcer perforation, severe renal impairment, and life‑threatening allergic reactions such as anaphylaxis or angio‑edema. Patients experiencing black stools, sudden kidney dysfunction, swelling of the face or difficulty breathing should seek immediate medical attention.

Ibugesic should be avoided by individuals with a known hypersensitivity to ibuprofen or any NSAID, those with active gastrointestinal ulceration or bleeding, patients with severe renal or hepatic impairment, and during the third trimester of pregnancy. Consultation with a healthcare professional is essential before initiating therapy in these populations.